Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP)
Launched by INSTITUT DE CHIRURGIE REPARATRICE LOCOMOTEUR ET SPORTS · Jul 15, 2021
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
Degenerative meniscal tear is a chronic, slowly evolving condition that typically involves horizontal cleavage of the meniscus and affects middle-aged men and women. The prevalence is high, with a medial meniscal tear found on imaging in 13-28% of persons older than 50 years of age. In the absence of evidence of knee osteoarthritis, only 22% of patients with meniscal tears have knee symptoms. Symptomatology is internal knee pain, often related to activities or positions such as squatting or kneeling, and usually improves with rest. The optimal treatment for nontraumatic degenerative menisca...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eligible for APM
- • Acceptance of infiltration procedure or APM
- • Patient age above 30 years and under 65 years
- • Acceptance of outpatient procedure
- • Non-locked painful knee ≥ 1 month
- • No osteoarthritis Kellgren-Lawrence ≤ 2 or Alhback ≤ 1 (Monopodal weh-ight-bearing AP and profile X-Ray with the knee in extension and bipedal schuss X-Ray with the knee at 45° of flexion
- • No malignment \> 5° (Full leg standing X-Ray)
- • Pain when squatting
- • Medial pain
- • MRI confirmed unique horizontal degenerative medial lesion
- Exclusion Criteria:
- • Traumatic meniscal injury
- • Neurological or rheumatic inflammatory diseases
- • MRI : Loose bodies or ligament injuries or osteochondral defects or tumors
- • Previous ipsilateral knee surgery
About Institut De Chirurgie Reparatrice Locomoteur Et Sports
The Institut de Chirurgie Réparatrice Locomoteur et Sports is a leading clinical research organization dedicated to advancing the field of orthopedic and sports medicine. With a focus on innovative surgical techniques and rehabilitative practices, the institute conducts rigorous clinical trials aimed at improving patient outcomes and enhancing functional recovery. By collaborating with multidisciplinary teams of healthcare professionals and leveraging cutting-edge technology, the institute strives to contribute to the body of knowledge in reparative surgery and promote evidence-based practices within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Trial Officials
Pascal Boileau, MD,PhD
Study Chair
ICR-Nice
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials